New hope for pancreatic cancer: experimental drug combo enters large trial
NCT ID NCT07490301
First seen Mar 26, 2026 · Last updated Jun 14, 2026 · Updated 16 times
Summary
This study tests whether adding an experimental drug called telisotuzumab adizutecan to standard chemotherapy (FOLFOX) helps people with advanced pancreatic cancer live longer or shrink their tumors. About 900 adults with pancreatic cancer that has spread will be randomly assigned to receive either the new combination or standard care. The trial runs in two phases to first find the best dose, then compare it to usual treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
China Medical University Hospital /ID# 279725
RECRUITINGTaichung, 40447, Taiwan
-
Fiona Stanley Hospital /ID# 280079
NOT_YET_RECRUITINGMurdoch, Western Australia, 6150, Australia
-
Monash Health - Monash Medical Centre - Clayton /ID# 280076
NOT_YET_RECRUITINGClayton, Victoria, 3168, Australia
-
Prince Of Wales Hospital - Randwick /ID# 280085
NOT_YET_RECRUITINGRandwick, New South Wales, 2031, Australia
-
Rambam Health Care Campus- Haifa /ID# 279409
RECRUITINGHaifa, 3109601, Israel
-
Tamworth Hospital /ID# 280099
NOT_YET_RECRUITINGNorth Tamworth, New South Wales, 2340, Australia
-
Tel Aviv Sourasky Medical Center /ID# 279414
RECRUITINGTel Aviv, Tel Aviv, 6423906, Israel
-
Texas Oncology - Northeast Texas /ID# 280417
RECRUITINGTyler, Texas, 75702, United States
-
The Cancer Institute Hospital Of JFCR /ID# 280140
RECRUITINGKoto-ku, Tokyo, 135-8550, Japan
Conditions
Explore the condition pages connected to this study.